Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Telomerase is a ribonucleoprotein complex that is required to synthesize DNA repeats at the ends of each chromosome. The RNA component of this reverse transcriptase is mutated in the bone marrow failure syndrome autosomal dominant dyskeratosis congenita. Here we show that disease anticipation is observed in families with this disease and that this is associated with progressive telomere shortening.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The most compelling evidence for the causal role of telomere shortening as a primary modifier of disease is that families with mutant telomerase genes display genetic anticipation39,83.”
From The telomere syndromes (2012) · cites this paper as [83]
In the citing paper
“Telomere length is influenced by many different factors, including age (13, 14) and the number of generations the mutation is transmitted (6, 15).”
From Adult-onset pulmonary fibrosis caused by mutations in telomerase (2007) · cites this paper as [15]
Citations
Cites
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
A telomerase component is defective in the human disease dyskeratosis congenita
Mitchell, J. R., Wood, E., & Collins, K. (1999) · Nature · doi:10.1038/990141 · Cited by 1,168
Greider, C. W. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.002005 · Cited by 1,021
Heiss, N. S., Knight, S. W., Vulliamy, T. J., Klauck, S. M., Wiemann, S., Mason, P. J., Poustka, A., & Dokal, I. (1998) · Nature Genetics · doi:10.1038/ng0598-32 · Cited by 976
Self-citationThe RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
Vulliamy, T., Marrone, A., Goldman, F., Dearlove, A., Bessler, M., Mason, P. J., & Dokal, I. (2001) · Nature · doi:10.1038/35096585 · Cited by 960
Self-citationDyskeratosis congenita in all its forms
Dokal, I. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02109.x · Cited by 575
Self-citationExtensive allelic variation and ultrashort telomeres in senescent human cells
Baird, D. M., Rowson, J., Wynford-Thomas, D., & Kipling, D. (2003) · Nature Genetics · doi:10.1038/ng1084 · Cited by 570
Function and synthesis of small nucleolar RNAs
Tollervey, D., & Kiss, T. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80005-1 · Cited by 467
Structure and polymorphism of human telomere-associated DNA
Brown, W. R. A., MacKinnon, P. J., Villasanté, A., Spurr, N., Buckle, V. J., & Dobson, M. J. (1990) · Cell · doi:10.1016/0092-8674(90)90293-n · Cited by 375
Association between aplastic anaemia and mutations in telomerase RNA
Vulliamy, T., Marrone, A., Dokal, I., & Mason, P. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09087-6 · Cited by 279
Self-citation
Cited by
Items 201–300 of 456
Mathur, S., Głogowska, A., McAvoy, E., Righolt, C. H., Rutherford, J., Willing, C., Banik, U., Ruthirakuhan, M. T., Mai, S., & Garcia, A. A. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-130866 · Cited by 40
Gramatges, M. M., Qi, X., Sasa, G., Chen, J. J. ‐., & Bertuch, A. A. (2013) · Blood · doi:10.1182/blood-2012-08-447755 · Cited by 44
“This was striking because a notable feature of both heterozygous TERT and TERC mutations is disease anticipation, resulting in an increasingly severe phenotype and earlier onset across successive generations, correlating with progressive telomere shortening.(7,33) In the reported families, however, although telomere l…”
BackgroundTelomeres and Telomerase in Stem Cells during Aging and Disease
Ju, Z., & Rudolph, K. L. (2006) · KARGER eBooks · doi:10.1159/000092502 · Cited by 44
Lifespan and telomere length variation across populations of wild‐derived African killifish
Reichard, M., Giannetti, K., Ferreira, T., Maouche, A., Vrtílek, M., Polačik, M., Blažek, R., & Ferreira, M. G. (2021) · Molecular Ecology · doi:10.1111/mec.16287 · Cited by 42
Familial nonmedullary thyroid cancer: Screening, clinical, molecular and genetic findings
Navas-Carrillo, D., Ríos, A., Rodríguez, J. M., Parrilla, P., & Orenes‐Piñero, E. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.09.002 · Cited by 49
Gansner, J. M., & Rosas, I. O. (2013) · Translational research · doi:10.1016/j.trsl.2013.04.001 · Cited by 43
Deficiency in DNA mismatch repair increases the rate of telomere shortening in normal human cells
Méndez-Bermúdez, A., & Royle, N. J. (2011) · Human Mutation · doi:10.1002/humu.21522 · Cited by 37
“The increased telomere shortening rate may also contribute to genetic anticipation between generations in Lynch syndrome families as seen in autosomal dominant Dyskeratosis Congenita (DC) [Vulliamy et al., 2001, 2004].”
BackgroundMedical genetics and epigenetics of telomerase
Koziel, J. E., Fox, M. J., Steding, C. E., Sprouse, A. A., & Herbert, B.-S. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01276.x · Cited by 36
Tabori, U., & Malkin, D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2091 · Cited by 35
“failure and premature aging syndrome, an association between telomere shortening and early onset and severity of disease has been found (24).”
BackgroundTelomere length maintenance in stem cell populations
Allen, N. D., & Baird, D. M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.004 · Cited by 41
“DC patients exhibit reduced haematopoiesis, reduced number of haematopoietic progenitors and colony forming ability [29, 30], and chromosomal instability phenotypes [31, 32] In addition, like telomerase knockout mice, DC patients display disease anticipation, whereby the severity and age of onset of the disease, get p…”
BackgroundIrvine, A. D., & Mellerio, J. E. (2010) · Wiley eBooks · doi:10.1002/9781444317633.ch15 · Cited by 38
Arias‐Salgado, E. G., Gálvez, E. H., Planas‐Cerezales, L., Pintado‐Berninches, L., Vallespín, E., Martínez, P., Carrillo, J., Iarriccio, L., Ruiz‐Llobet, A., Català, A., et al. (2019) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-019-1046-0 · Cited by 37
Capezzone, M., Cantara, S., Marchisotta, S., Busonero, G., Formichi, C., Benigni, M., Capuano, S., Toti, P., Pazaitou‐Panayiotou, K., Caruso, G., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1003 · Cited by 42
Telomeres in dyskeratosis congenita
Shay, J. W., & Wright, W. E. (2004) · Nature Genetics · doi:10.1038/ng0504-437 · Cited by 40
Understanding telomere diseases through analysis of patient-derived iPS cells
Batista, L. F. Z., & Artandi, S. E. (2013) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.07.006 · Cited by 36
Du, H., Idol, R. A., Robledo, S. M., Ivanovich, J. L., An, P., Londoño‐Vallejo, A., Wilson, D. B., Mason, P. J., & Bessler, M. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00324.x · Cited by 37
“It explains the increasing severity and younger age of onset of the disease in later generations in patients with autosomal dominant DC (Vulliamy et al., 2001, 2004; Mason, 2003; Armanios et al., 2005; Goldman et al., 2005).”
BackgroundSelf-citationCell intrinsic and extrinsic mechanisms of stem cell aging depend on telomere status
Song, Z., Ju, Z., & Rudolph, K. L. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.06.009 · Cited by 38
“Lastly, mutations in human telomerase genes lead to telomere shortening, stem cell defects, impaired organ maintenance and a shortened lifespan (Armanios et al., 2007; Tsakiri et al., 2007; Vulliamy et al., 2004).”
BackgroundFiesco-Roa, M. Ó., Teresa, B. G., Leal-Anaya, P., Hek, R. V., Wegman-Ostrosky, T., Frías, S., & Rodríguez, A. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.949435 · Cited by 40
Jackson, S.-R., Lee, J., Reddy, R., Williams, G. N., Kikuchi, A., Freiberg, Y., Warburton, D., & Driscoll, B. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00409.2010 · Cited by 33
“Telomerase is active in proliferation-competent progenitors within a variety of organs, including lung, and correlates with selfrenewal capacity (16, 20, 24, 33, 39, 59).”
BackgroundStress, social rank and leukocyte telomere length
Lansdorp, P. M. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00247.x · Cited by 32
Dyskerin, telomerase and the DNA damage response
Gu, B.-W., Bessler, M., & Mason, P. J. (2009) · Cell Cycle · doi:10.4161/cc.8.1.7265 · Cited by 31
Self-citationVuong, L. G., Hemmati, P., Neuburger, S., Terwey, T. H., Vulliamy, T., Dokal, I. S., le Coutre, P., Dörken, B., & Arnold, R. (2010) · Acta Haematologica · doi:10.1159/000318721 · Cited by 30
“DC has been primarily thought of as an X-linked disease, but autosomal recessive and dominant patterns of inheritance have been identified as well. The gene responsible for the X-linked form encodes a protein (dyskerin) involved in the stabilization of telomerase and other small nucleolar ribonucleoprotein complexes,…”
BackgroundSelf-citationNing, X., Zhang, N., Li, T., Wu, P., Wang, X., Li, X., Peng, S., Wang, J., Chen, J.-C., & Gong, K. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0024 · Cited by 31
Boonstra, P. S., Gruber, S. B., Raymond, V. M., Huang, S., Timshel, S., Nilbert, M. C., & Mukherjee, B. (2010) · Genetic Epidemiology · doi:10.1002/gepi.20534 · Cited by 30
“Recently, telomere shortening has been suggested as the mechanism for anticipation [Vulliamy et al., 2004].”
Telomere Length as a Marker of Biological Aging: A Critical Review of Recent Literature
Daios, S., Anogeianaki, A., Kaiafa, G. D., Kontana, A., Veneti, S., Gogou, C., Karlafti, E., Pilalas, D., Kanellos, I., & Savopoulos, C. G. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220713123750 · Cited by 33
Telomere dysfunction in human diseases: the long and short of it!
Carroll, K. A., & Ly, H. (2009) · Europe PMC (PubMed Central) · Cited by 40
Baird, D. M. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.09.009 · Cited by 39
The evolving genetic landscape of telomere biology disorder dyskeratosis congenita
Tummala, H., Walne, A. J., Badat, M., Patel, M., Walne, A. M., Alnajar, J., Chow, C. C., Albursan, I., Frost, J. M., Ballard, D., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00118-x · Cited by 35
“In addition, disease severity may increase in succeeding generations due to the inheritance of short telomeres, known as the anticipation phenomenon (Vulliamy et al, 2004).”
Self-citationIskandar, M., Barbero, M. X., Jaber, M. T., Chen, R., Gomez-Guevara, R., Cruz, E., & Westerheide, S. D. (2025) · Cancers · doi:10.3390/cancers17020257 · Cited by 35
Essential roles for Pot1b in HSC self-renewal and survival
Wang, Y., Shen, M., & Chang, S. S. (2011) · Blood · doi:10.1182/blood-2011-06-361527 · Cited by 31
Liu, N., Yin, Y., Wang, H., Zhou, Z., Sheng, X., Fu, H., Guo, R., Wang, H., Yang, J., Gong, P., et al. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008368 · Cited by 29
“Dyskerin, TERT, TERC) exhibit telomere shortening and skin atrophy [7].”
BackgroundTelomerase and telomere biology in hematological diseases: A new therapeutic target
Allegra, A., Innao, V., Penna, G., Gerace, D. G., Allegra, A. G., & Musolino, C. (2017) · Leukemia Research · doi:10.1016/j.leukres.2017.02.002 · Cited by 39
Field, J. J., Mason, P. J., An, P., Kasai, Y., McLellan, M. D., Jaeger, S. R., Barnes, Y. J., King, A. A., Bessler, M., & Wilson, D. B. (2006) · Journal of Pediatric Hematology/Oncology · doi:10.1097/01.mph.0000212952.58597.84 · Cited by 28
“In autosomal dominant DC, anticipation has been attributed to the inheritance of progressively shortened chromosomal ends, which occurs in a Mendelian fashion.(3,4) Still, the autosomal dominant form of DC is typically mild; many patients present with only bone marrow failure and are indistinguishable from individuals…”
BackgroundSelf-citationPulmonary fibrosis in non‐mutation carriers of families with short telomere syndrome gene mutations
van der Vis, J. J., van der Smagt, J. J., van Batenburg, A. A., Goldschmeding, R., van Es, H. W., Grutters, J. C., & van Moorsel, C. H. M. (2021) · Respirology · doi:10.1111/resp.14145 · Cited by 29
“A hallmark of families with STS is genetic anticipation, meaning that when the genetic disorder is passed on to the next generation the offspring will manifest disease at an earlier age and with increased disease severity.(7,8) In this study, pedigrees display genetic anticipation and a spectrum of STS phenotypes.”
BackgroundDyskeratosis congenita: clinical report and review of the literature
Baran, İ., Nalçacı, R., & Kocak, M. (2009) · International Journal of Dental Hygiene · doi:10.1111/j.1601-5037.2009.00364.x · Cited by 28
Telomere Length Is Shorter in Affected Members of Families with Familial Nonmedullary Thyroid Cancer
He, M., Bian, B., Gesuwan, K., Gulati, N., Zhang, L., Nilubol, N., & Kebebew, E. (2012) · Thyroid · doi:10.1089/thy.2012.0270 · Cited by 29
“Short telomere length and genetic defects in telomere maintenance have been associated with increased risk of cancers (breast, bladder, lung, and gastrointestinal); familial diseases, such as dyskeratosis congenital syndrome (17); and familial cancers, including papillary thyroid cancer (18).”
Decreased telomere length in children with cartilage-hair hypoplasia
Vakkilainen, S., Degerman, S., Pekkinen, M., Klemetti, P., Landfors, M., Roos, G., Taskinen, M. H., & Mäkitie, O. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-104279 · Cited by 26
Novel variants in Nordic patients referred for genetic testing of telomere-related disorders
Norberg, A., Rosén, A., Raaschou‐Jensen, K., Kjeldsen, L., Moilanen, J. S., Paulsson-Karlsson, Y., Baliakas, P., Lohi, O., Ahmed, A. B., Kittang, A. O., et al. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-018-0112-8 · Cited by 27
“Furthermore, due to genetic anticipation, it is common to have members of younger generations presenting earlier in life compared with older generations within a family [8].”
Multiple Solid Organ Transplantation in Telomeropathy: Case Series and Literature Review
Lebeer, M., Wuyts, W. A., Cassiman, D. M., Laleman, W., Nevens, F., Pirenne, J., Monbaliu, D. R. L., Roskams, T., Verbeken, E. K., Neyrinck, A., et al. (2018) · Transplantation · doi:10.1097/tp.0000000000002198 · Cited by 28
Dreesen, O. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190882 · Cited by 30
Richard, M. A., Lupo, P. J., Morton, L. M., Yasui, Y., Sapkota, Y., Arnold, M., Aubert, G., Neglia, J. P., Turcotte, L. M., Leisenring, W. M., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228887 · Cited by 29
La dyskératose congénitale: Une maladie méconnue due à un maintien défectueux des télomères
Hoareau‐Aveilla, C., Henry, Y. A. L., & Leblanc, T. M. (2008) · médecine/sciences · doi:10.1051/medsci/2008244390 · Cited by 34
Telomere Length and Genetic Anticipation in Lynch Syndrome
Seguí, N., Pineda, M., Guinó, E., Borràs, E., Navarro, M., Bellido, F., Moreno, V. R., Lázaro, C., Blanco, I., Capellá, G., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061286 · Cited by 29
Wang, H., Zhuang, Y., Peng, H., Cao, M., Li, Y., Xu, Q., Xin, X., Zhou, K., Liang, G., Cai, H., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-51902-6 · Cited by 28
Treatment of acquired aplastic anemia
Marsh, J. C. W. (2007) · Haematologica · doi:10.3324/haematol.11107 · Cited by 25
“Patients with so called cryptic dyskeratosis congenita characterized by mutations in telomerase genes, TERC or TERT, lack the somatic changes of classical dyskeratosis congenita and invariably fail to respond to immunosuppressive therapy.(2,3) All patients should be screened for cytogenetic and paroxysmal nocturnal he…”
BackgroundTelomere biology disorders: time for moving towards the clinic?
Batista, L. F. Z., Dokal, I. S., & Parker, R. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.08.001 · Cited by 27
Self-citationSjøgren, T., Bratland, E., Røyrvik, E. C., Grytaas, M. A., Benneche, A., Knappskog, P. M., Kämpe, O., Oftedal, B. E., Husebye, E. S., & Wolff, A. S. B. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102917 · Cited by 24
Familial multiple sclerosis and association with other autoimmune diseases
Pytel, V., Matías‐Guiu, J. A., Torre‐Fuentes, L., Montero, P., Gómez‐Graña, Á., García-Ramos, R., Moreno‐Ramos, T., Oreja‐Guevara, C., Fernández‐Arquero, M., Gómez‐Pinedo, U., et al. (2017) · Brain and Behavior · doi:10.1002/brb3.899 · Cited by 24
“AP is attributed to a number of genetic mechanisms, including expansion of an unstable nucleotide repeat, as in Huntington disease and myotonic dystrophy type 1, and telomere shortening, as in dyskeratosis congenita (Vulliamy et al., 2004) and breast cancer (Martinez- Delgado et al.”
BackgroundDysfunctional telomeres and hematological disorders
Fiorini, E., Santoni, A., & Colla, S. (2018) · Differentiation · doi:10.1016/j.diff.2018.01.001 · Cited by 26
“shortening occurring in later generations (Armanios et al., 2005; Vulliamy et al., 2004).”
BackgroundBone Marrow Failure: A Child Is Not Just a Small Adult (But an Adult Can Have a Childhood Disease)
Alter, B. P. (2005) · Hematology · doi:10.1182/asheducation-2005.1.96 · Cited by 25
Sharma, A., Myers, K. C., Ye, Z., & D'Orazio, J. A. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25161 · Cited by 24
“Genetic anticipation has been described in other cases of autosomal dominant cases of DC, presumably because of telomerase haploinsufficiency and decreased telomere length over successive generations [10,14].”
BackgroundUeda, Y., Calado, R. T., Norberg, A., Kajigaya, S., Roos, G., Hellström‐Lindberg, E., & Young, N. S. (2014) · BMC Medical Genetics · doi:10.1186/1471-2350-15-68 · Cited by 24
Telomeres, cell senescence and human ageing
von Zglinicki, T., Martin-Ruiz, C. M., & Saretzki, G. C. (2005) · Signal Transduction · doi:10.1002/sita.200400049 · Cited by 28
Human short-term repopulating cells have enhanced telomerase reverse transcriptase expression
Järås, M., Edqvist, A., Rebetz, J., Salford, L. G., Widegren, B., & Fan, X. (2006) · Blood · doi:10.1182/blood-2005-09-008904 · Cited by 24
Generation or birth cohort effect on cancer risk in Li–Fraumeni syndrome
Brown, B. W., Costello, T. J., Hwang, S., & Strong, L. C. (2005) · Human Genetics · doi:10.1007/s00439-005-0016-x · Cited by 25
“…Cancer Genetics, Unit 209, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA tion carriers in general had shorter telomeres than the age adjusted normal population, with significantly shorter telomeres observed in the subsequent generations (Vulliamy et al. 2004).”
BackgroundTelomeres: Dysfunction, Maintenance, Aging and Cancer
Liao, P., Yan, B., Wang, C., & Lei, P. (2023) · Aging and Disease · doi:10.14336/ad.2023.1128 · Cited by 36
Telomere-lengthening germline variants predispose to a syndromic papillary thyroid cancer subtype
DeBoy, E. A., Nicosia, A. M., Liyanarachchi, S., Iyer, S., Shah, M. H., Ringel, M. D., Brock, P. L., & Armanios, M. Y. (2024) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2024.04.006 · Cited by 25
Familial Interstitial Lung Disease
Kropski, J. A. (2020) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0040-1708054 · Cited by 23
Mutations of Telomerase Complex Genes Linked to Bone Marrow Failures
Yamaguchi, H. (2007) · Journal of Nippon Medical School · doi:10.1272/jnms.74.202 · Cited by 25
Retinal vasculopathy in a family with autosomal dominant dyskeratosis congenita
Johnson, C. A., Hatfield, M., & Pulido, J. S. (2009) · Ophthalmic Genetics · doi:10.3109/13816810903148012 · Cited by 21
Dysfunctional telomeres and dyskeratosis congenita
Bessler, M., Du, H., Gu, B., & Mason, P. J. (2007) · Haematologica · doi:10.3324/haematol.11221 · Cited by 27
Self-citationThe genetic basis of bone marrow failure syndromes in children
Federman, N. C., & Sakamoto, K. M. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2005.07.006 · Cited by 20
Vittal, A., Niewisch, M. R., Bhala, S., Kudaravalli, P., Rahman, F., Hercun, J., Kleiner, D. E., Savage, S. A., Koh, C., Heller, T., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000461 · Cited by 24
“[9,10] The prevalence of liver disease in patients with known DC is estimated to be ~5% – 10%, but this has not been systematically studied.”
BackgroundCarrillo, J., González, A., Manguán-García, C., Pintado‐Berninches, L., & Perona, R. (2013) · Clinical & Translational Oncology · doi:10.1007/s12094-013-1112-3 · Cited by 21
“Mostly, these reports are based on the inhibition of Nop10 [4] or Dkc1 [5] expression in zebrafish, or mouse expressing an hypomorphic Dkc1 mutant [19].”
BackgroundStem cell function and maintenance – ends that matter: Role of telomeres and telomerase
Saeed, H., & Iqtedar, M. (2013) · Journal of Biosciences · doi:10.1007/s12038-013-9346-3 · Cited by 24
Cantara, S., Capuano, S., Capezzone, M., Benigni, M., Pisu, M., Marchisotta, S., & Pacini, F. (2012) · Thyroid · doi:10.1089/thy.2011.0109 · Cited by 19
“In DC, TERC mutations and short telomeres are responsible for the familial form (14, 27).”
Bilateral Retinal Vasculopathy Associated with Autosomal Dominant Dyskeratosis Congenita
Vaz-Pereira, S., Pacheco, P. A., Gandhi, S., Kulasekararaj, A. G., Marsh, J. C. W., Pal, B., & Mufti, G. J. (2013) · European Journal of Ophthalmology · doi:10.5301/ejo.5000297 · Cited by 19
“Many families have been described with asymptomatic carriers of TERC mutations in early generations and symptomatic individuals with onset of symptoms occurring at younger age in succeeding generations, demonstrating the phenomena of disease anticipation (1, 2).”
BackgroundAnticancer Therapy Targeting Telomeres and Telomerase: Current Status
Parkinson, E. K., & Minty, F. (2007) · BioDrugs · doi:10.2165/00063030-200721060-00005 · Cited by 22
Capezzone, M., Marchisotta, S., Cantara, S., & Pacini, F. (2009) · Current Genomics · doi:10.2174/138920209789503897 · Cited by 22
“Interestingly, patients who have inherited or acquired genetic defects in telomere maintenance seem to have an increased risk of developing familial benign diseases such as dyskeratosis congenital syndrome [19] and malignant diseases such as head, neck, lung, breast and renal cancers [20].”
BackgroundSomatic mutation panels: Time to clear their names
Trottier, A. M., Silva, M. C. D. A., Li, Z., & Godley, L. A. (2019) · Cancer Genetics · doi:10.1016/j.cancergen.2019.04.065 · Cited by 20
Genetic predisposition to porto-sinusoidal vascular disorder
Ciriaci, N., Bertin, L., & Rautou, P. (2024) · Hepatology · doi:10.1097/hep.0000000000000973 · Cited by 21
“[8,47] Patients with PSVD and telomere biology disorders commonly had hepatopulmonary syndrome (n = 15/34, 44%), a condition rarely reported with other genetic mutations.”
BackgroundFeatures and outcome of familial idiopathic pulmonary fibrosis.
Ravaglia, C., Tomassetti, S., Gurioli, C., Piciucchi, S., Dubini, A., Gurioli, C., Casoni, G. L., Romagnoli, M., Carloni, A., Tantalocco, P., et al. (2014) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 21
Telomere Dysfunction and Hematologic Disorders
Paiva, R. M. A., & Calado, R. T. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397898-1.00006-2 · Cited by 20
Evidence for genetic anticipation in vonHippel-Lindau syndrome
Aronoff, L., Malkin, D. M., van Engelen, K., Gallinger, B., Wasserman, J. D., Kim, R. H., Villani, A., Meyn, M. S., & Druker, H. A. (2018) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2017-104882 · Cited by 19
Understanding Idiopathic Interstitial Pneumonia: A Gene-Based Review of Stressed Lungs
van Moorsel, C. H. M., Hoffman, T. W., van Batenburg, A. A., Klay, D., van der Vis, J. J., & Grutters, J. C. (2015) · BioMed Research International · doi:10.1155/2015/304186 · Cited by 20
“However, carriers of mutations that cause a minor decrease in overall telomerase activity were shown to cause significant reduction of telomere length over generations that will eventually lead to telomere syndromes [55, 56, 59].”
BackgroundThe Cell Biology of Stem Cells
Meshorer, E., & Plath, K. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-7037-4 · Cited by 23
Telomerase as a clinical target: Current strategies and potential applications
Fleisig, H. B., & Wong, J. M. Y. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.05.011 · Cited by 23
A role for sister telomere cohesion in telomere elongation by telomerase
Houghtaling, B. R., Canudas, S., & Smith, S. H. (2012) · Cell Cycle · doi:10.4161/cc.11.1.18633 · Cited by 21
Al-Ajmi, N., Saretzki, G. C., Miles, C. G., & Spyridopoulos, I. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.07.010 · Cited by 18
Marsh, J. C. W. (2005) · Clinical Medicine · doi:10.7861/clinmedicine.5-4-332 · Cited by 17
Kristinsson, S. Y., Goldin, L. R., Turesson, I., Björkholm, M., & Landgren, O. (2012) · Acta Haematologica · doi:10.1159/000335618 · Cited by 16
Nichele, S., Bonfim, C., Darrigo, L. G., Loth, G., Kuwahara, C. C., Trennephol, J., Funke, V. A. M., Marinho, D. H., Koliski, A., Rodrigues, A. M., et al. (2023) · European Journal Of Haematology · doi:10.1111/ejh.14023 · Cited by 18
Kristinsson, S. Y., Koshiol, J. E., Goldin, L. R., Björkholm, M., Turesson, I., Gridley, G., McMaster, M. L., & Landgren, O. (2009) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2009.n.004 · Cited by 16
Takaoka, K., Kawazu, M., Koya, J., Yoshimi, A., Masamoto, Y., Maki, H., Toya, T., Kobayashi, T., Nannya, Y., Arai, S., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0385-0 · Cited by 15
Telomeric chromatin: Roles in aging, cancer and hereditary disease
McCord, R., & Broccoli, D. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.08.005 · Cited by 23
Anticipation in Lynch Syndrome: Still Waiting for the Answer
Gruber, S. B., & Mukherjee, B. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.1445 · Cited by 15
“Here the mechanism of anticipation also appears to be related to shortening telomeres in successive generations.(6) It is also worthwhile to review the statistical approaches that are required to answer this complicated problem.”
BackgroundPavlaki, K. I., Kastrinaki, M.-C., Klontzas, M. E., Velegraki, M., Mavroudi, I., & Papadaki, H. Α. (2011) · Haematologica · doi:10.3324/haematol.2011.053983 · Cited by 15
Analysis of telomere dynamics in peripheral blood cells from patients with Lynch syndrome
Bozzao, C., Lastella, P., de Leòn, M. P., Pedroni, M., Gregorio, C. D., D'Ovidio, F. D., Resta, N., Prete, F., Guanti, G., & Stella, A. (2011) · Cancer · doi:10.1002/cncr.26022 · Cited by 14
“In this progressive bone marrow failure syndrome, anticipation has been associated with progressive telomere shortening in patients with an increased predisposition to malignancy.(8) Human telomeres extend over several thousand kilo base pairs (kbs) of DNA sequence at the end of each chromosome and consist of TTAGGG t…”
BackgroundLate manifestation of dyskeratosis congenita presenting as chronic dermal ulcer in a 37‐year‐old man
Reimann, C., Kloeckener‐Gruissem, B., Niemeyer, C. M., & Vanscheidt, W. (2008) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2007.02530.x · Cited by 14
Clues For Genetic Anticipation In Multiple Endocrine Neoplasia Type 1
van den Broek, M. F. M., van Nesselrooij, B. P. M., Pieterman, C. R. C., Stuart, A. A. V., van de Ven, A. C., de Herder, W. W., Dekkers, O. M., Drent, M. L., Havekes, B., Kerstens, M. N., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa257 · Cited by 14
“In 2004, Vulliamy et al found an association between clinical anticipation and a significant decrease in telomere length in successive generations in autosomal dominant dyskeratosis congenita, possibly owing to haploinsufficiency of the affected gene encoding the RNA component of telomerase (TERC) (10).”
BackgroundHenriques, C. M., & Ferreira, M. G. (2024) · Disease Models & Mechanisms · doi:10.1242/dmm.050581 · Cited by 15
Telomere dynamics in induced pluripotent stem cells: Potentials for human disease modeling
Ly, H. (2011) · World Journal of Stem Cells · doi:10.4252/wjsc.v3.i10.89 · Cited by 12
Allogeneic hematopoietic stem cell transplantation for dyskeratosis congenita
Elmahadi, S., Muramatsu, H., & Kojima, S. (2016) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000290 · Cited by 17
“All rights rese Many reports determined that genetic anticipation leads to a younger age of onset and increased severity of dyskeratosis congenita symptoms in the offspring than the parents [23].”
BackgroundKuhn, J., Brümmendorf, T. H., Brassat, U., Lehnhardt, F. G., Chung, B.-D., Harnier, S., Bewermeyer, H., Harzheim, A., Assheuer, J., & Netzer, C. (2008) · European Neurology · doi:10.1159/000186506 · Cited by 15
“Recently, a second mechanism for disease anticipation has been established: in dyskeratosis congenita, a disorder characterized by cutaneous abnormalities and bone marrow failure, progressive telomere shortening leads to increased disease severity and/or earlier disease onset from generation to generation in families…”
BackgroundEffects of p21 deletion in mouse models of premature aging
Benson, E. K., Zhao, B., Sassoon, D. A., Lee, S. W., & Aaronson, S. A. (2009) · Cell Cycle · doi:10.4161/cc.8.13.8997 · Cited by 16
Maliński, B., Vertemara, J., Faustini, E., Ladenvall, C., Norberg, A., Zhang, Y., von Castelmur, E., Baliakas, P., Tisi, R., Cammenga, J., et al. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad114 · Cited by 14
Polygenic modifiers impact penetrance and expressivity in telomere biology disorders
Poeschla, M., Arora, U. P., Walne, A. J., McReynolds, L. J., Niewisch, M. R., Giri, N., Zeigler, L. P., Gusev, A., Machiela, M. J., Tummala, H., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci191107 · Cited by 14
Self-citationTelomere dysfunction in human bone marrow failure syndromes
Shtessel, L., & Ahmed, S. C. (2011) · Nucleus · doi:10.4161/nucl.2.1.13993 · Cited by 15
Järås, M., Brun, A. C. M., Karlsson, S., & Fan, X. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2006.11.004 · Cited by 15
Corbett, N., & Alda, M. (2015) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.140347 · Cited by 12
Metadata
- Authors
- Vulliamy, T., Marrone, A., Szydlo, R., Walne, A., Mason, P. J., & Dokal, I.
- Affiliations
- Hammersmith Hospital (GB)
- Washington University in St. Louis (US)
- Corresponding author
- Mason, Philip J
- Venue
- Nature Genetics
- Published
- 2004-04-18
- Volume
- 36
- Issue
- 5
- Pages
- 447-449
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2025843494
- Cited by
- 461
- References
- 15
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 14 · 2023: 11 · 2022: 17 · 2021: 16 · 2020: 19 · 2019: 17 · 2018: 14 · 2017: 13 · 2016: 18 · 2015: 15 · 2014: 28 · 2013: 26 · 2012: 15
- FWCI
- 20.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Keywords
- dyskeratosis congenita, telomere shortening, TERC mutations, telomerase RNA, telomerase, bone marrow failure, autosomal dominant inheritance
- MeSH terms
- Adolescent, Adult, Child, Child, Preschool, Family, Female, Genes, Dominant, Humans, Male, Middle Aged, Mutation, Pedigree, RNA, Telomere, Sequence Deletion, Telomerase, Dyskeratosis Congenita
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.